Nutex health announces nasdaq delisting notification and stay pending ongoing appeal. no immediate effect on the listing or trading of the common stock.

Houston , may 24, 2024 /prnewswire/ -- nutex health inc. ("nutex health" or the "company") (nasdaq: nutx), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter  on may21, 2024 from the listing qualifications department  of the nasdaq stock market llc ("nasdaq") notifying the company that, due to the company's non-compliance with the minimum $1.00 bid price requirement set forth in nasdaq listing rule 5550(a)(2) (the "minimum bid price requirement"), the company's common stock would be scheduled for delisting from the nasdaq capital market and would be suspended for trading at the opening of business on may 30, 2024 unless the company timely requests a hearing before an independent nasdaq hearings panel (the "panel") by may 28, 2024.  on may 23, 2024, the company submitted a request for a hearing to appeal the staff's delisting determination.
NUTX Ratings Summary
NUTX Quant Ranking